Mode
Text Size
Log in / Sign up

EV-associated proteins and miRNAs provide high diagnostic accuracy for Lichen Planus and Oral Lichen PlanusNew markers show promise for diagnosing Lichen Planus cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that EV-associated markers like GJA1 and Cx43 show high diagnostic accuracy for Lichen Planus and Oral Lichen Planus.

This meta-analysis evaluates the diagnostic accuracy of extracellular vesicle (EV) associated miRNA and protein biomarkers in individuals with Lichen Planus (LP) and Oral Lichen Planus (OLP). The study synthesized data from 298 individuals with LP, 194 controls, and 261 individuals with OLP to determine the utility of these markers as diagnostic tools.

The analysis identified several promising biomarkers. Specifically, miR-4484 demonstrated good diagnostic utility with an AUC of 0.81. The combination of GJA1 and Cx43 showed the strongest discriminatory ability with an AUC of 0.892. Overall, the meta-analysis of diagnostic accuracy yielded a pooled AUC of 0.89 for these biomarkers.

Limitations noted by the authors include small sample sizes and methodological heterogeneity across the included studies. While the results are promising, miR-4484, miR-34a-5p, GJA1, PDIA3, and Cx43 are currently considered potential candidates rather than confirmed definitive biomarkers. These markers may provide further insight into the inflammatory and immune mechanisms involved in OLP pathogenesis.

How this fits prior evidence

This meta-analysis addresses a gap in identifying reliable diagnostic tools for Lichen Planus and Oral Lichen Planus. While prior coverage identified oral microbiome dysbiosis as a potential contributor to malignant transformation in oral lichen planus, this study focuses on the diagnostic utility of EV-associated biomarkers like GJA1 and Cx43 (AUC 0.892) to identify these conditions.

Living with Lichen Planus can be frustrating because it is an inflammatory condition that affects the skin and mouth. Identifying exactly what is happening in the body during these flare-ups is a major challenge for doctors trying to provide the best care.

A large review of data looked at small particles in the body called extracellular vesicles. These tiny carriers carry proteins and genetic material, known as miRNA. The study found that certain markers, like miR-4484 and a combination of GJA1 and Cx43, showed good to strong ability to distinguish those with the condition from healthy people.

While these findings are promising for identifying the disease and understanding how it causes tissue injury, there is still work to do. The study notes that some sample sizes were small and methods varied across different tests. These markers are currently considered potential candidates rather than confirmed tools for everyday use.

What this means for you:
Specific proteins and genetic markers show strong potential as tools to help diagnose Lichen Planus and Oral Lichen Planus.

Common questions

What are these new biomarkers?

The study looked at extracellular vesicles, which are tiny particles in the body. These carry specific markers like miR-4484 and a combination of GJA1 and Cx43. These markers showed good to strong ability to help distinguish people with Lichen Planus or Oral Lichen Planus from those without the condition.

How accurate are these tests for diagnosis?

The research showed that the combination of GJA1 and Cx43 had the strongest ability to differentiate cases, with a score of 0.892. Overall, the pooled results for these markers showed good discrimination in identifying the condition.

Are these tests ready to use in clinics?

Not yet. While these proteins and genetic markers are promising candidates for diagnosis and understanding how the disease causes injury, they are not yet confirmed as definitive biomarkers. The study noted some limitations like small sample sizes and different testing methods.

Study Details

Study typeMeta analysis
Sample sizen = 10
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Background Lichen Planus (LP) is a chronic inflammatory disorder that can affect the skin, hair, nails, and mucous membranes. Oral lichen planus (OLP), the most common LP subtype, is a disease of the oral mucosa, often diagnosed through clinical examination and histopathological confirmation. Extracellular vesicles (EVs) transfer proteins, lipids, and nucleic acids among cells and have become increasingly studied for their potential as minimally invasive diagnostic biomarkers and therapeutic agents in inflammatory and autoimmune diseases. Methods PUBMED and Embase were searched from inception through June 27th, 2026. Human studies investigating EV-associated miRNA or protein biomarkers in LP and its subtypes were included, with risk of bias assessed using a modified Newcastle-Ottawa Scale. Diagnostic accuracy was evaluated using receiver operating characteristic (ROC) and BRMA models when sufficient data were available. Results Ten articles met the inclusion criteria, encompassing biomarker discovery, functional, and mechanistic studies of EVs in OLP. These included studies (n = 10) comprised 298 individuals with LP (weighted mean age 50.7 years; 61.5% female) and 194 controls (weighted mean age 47.8 years; 58.5% female). OLP-specific cohorts (n = 9 studies) included 261 individuals with OLP (weighted mean age 50.7 years; 61.4% female). Although no individual EV-associated miRNAs or proteins overlapped across studies, EV-associated miRNAs demonstrated substantial heterogeneity, while EV-associated protein findings centered on pathways related to antigen presentation, inflammatory signaling, and immune activation. Several candidate biomarkers, including miR-4484, miR-34a-5p, GJA1, PDIA3, and Cx43, showed potential diagnostic or prognostic relevance. ROC analyses demonstrated good diagnostic utility for miR-4484 (AUC = 0.81), and the combination of GJA1 and Cx43 showed the strongest discriminatory ability (AUC = 0.892). The diagnostic accuracy meta-analysis showed good discrimination (pooled AUC = 0.89). Functional and mechanistic studies suggested that EVs may actively contribute to OLP pathogenesis through promoting epithelial injury and activating inflammatory signalling pathways. Conclusions EV-associated miRNAs and proteins are potential biomarker candidates for LP and may provide insight into the inflammatory and immune mechanisms underlying disease pathophysiology. Functional and mechanistic evidence further suggests that EVs may play an active role in disease progression. However, current evidence has limitations such as small sample sizes and methodological heterogeneity. Larger, standardized, and longitudinal studies are needed to v
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.